LETTER TO EDITOR
Cardiac implantable electronic device discharge during intrathoracic tumour radiofrequency ablation
Anh Ngo
1
1
Beth Israel Deaconess Medical Center, Department of Anesthesia Critical Care, and Pain Medicine, Harvard Medical School, Boston, MA, USA
2
Georgetown University School of Medicine, Washington, DC, USA
3
Valley Anesthesiology and Pain Consultants, Phoenix, AZ, USA
4
Creighton University School of Medicine, Department of Anesthesia, Omaha, NE, USA
5
University of Arizona College of Medicine-Phoenix, Department of Anesthesia, Phoenix, AZ , USA
Publication date: 2019-08-30
Anaesthesiol Intensive Ther 2019;51(3):249-252
REFERENCES (11)
1.
Goldberger Z, Lampert R. Implantable cardioverter- defibrillators. JAMA 2006; 295: 809-818. doi: 10.1001/jama.295.7.809.
3.
Sweesy MW, Holland JL, Smith KW. Electromagnetic interference in cardiac rhythm management devices. AACN Clin Issues 2004; 15: 391-403.
4.
Apfelbaum J, Belott P, Connis R, et al. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Implantable Electronic Devices. Anesthesiology 2011; 114: 247-261. doi: 10.1097/ALN. 0b013e3181fbe7f6.
5.
Skonieczki BD, Wells C, Wasser EJ, et al. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol 2011; 79: 343-346. doi: 10.1016/j.ejrad.2010.04.004.
6.
Donohoo JH, Anderson MT, Mayo-Smith WW. Pacemaker reprogramming after radiofrequency ablation of a lung neoplasm. Am J Roentgenol 2007; 189: 890-892.
7.
Mahnken AH, Wehowsky S, Brehmer B, Günther RW. Renal radiofrequency ablation in a patient with an internal cardioverter defibrillator. J Vasc Interv Radiol 2006; 17: 1858-1859. doi: 10.1097/01.RVI.0000236592.98646.0F.
8.
Asensio EL, López TG, Guerrero MH, et al. Radiofrequency ablation of a hepatic neoplasm in a patient with an abdominal pacemaker. Cardiol J 2009; 16: 264-268.
9.
Hayes DL, Charboneau JW, Lewis BD, Asirvatham SJ, Dupuy DE, Lexvold NY. Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers. Mayo Clin Proc 2001; 76: 950-952. doi: 10.4065/76.9.950.
10.
Chin MC, Rosenqvist M, Lee MA, Griffin JC, Langberg JJ. The effect of radiofrequency catheter ablation on permanent pacemakers: an experimental study. Pacing Clin Electrophysiol 1990; 13: 23-29. doi: 10.1111/j.1540-8159.1990.tb01999.x.
11.
Brace C. Thermal tumor ablation in clinical use. IEEE Pulse 2011; 2: 28-38. doi: 10.1109/MPUL. 2011.942603.
| eISSN: | 1731-2531 |
| ISSN: | 1642-5758 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
